Laser device aims to zap away back pain without drugs
NCT ID NCT07661082
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called BTL-043 that uses a combination of laser energy and TriHIL technology to treat back pain. Twenty-four adults with chronic back pain will receive four 30-minute treatment sessions over a few weeks. Researchers will measure changes in pain levels and disability using standard questionnaires up to three months after treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- BTL-043 device (EMVITAL) using TriHIL technology with 1064 nm near-infrared laser
- What this could lead to
- If it works, this could offer a non-invasive, drug-free option for reducing chronic back pain and improving daily function.
- What could go wrong
- This is a very small, early study with only 24 participants and no comparison group, so results may not apply broadly. Pain relief may be temporary or no better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Mar 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult subjects seeking treatment for alleviating back pain, and expressing interest in treatment will be considered eligible for the study. * Enrollment of the subject will depend on meeting the following criteria: * Adults seeking alleviation of pain in the treatment area * Age 22 years and older * Voluntarily signed an informed consent form * Subject is willing to comply with study instructions, to return to the clinic for the required visits * Willingness to adhere to and continue current pain management plan * Subjects willing and able to maintain their regular (pre-procedure) diet, exercise, and therapy regimen without affecting significant change during study participation * Subject willing and able to abstain from partaking in any new treatments other than this study procedure to treat back pain * Women of child-bearing potential\* are required to use birth control measures during the whole duration of the study * Women of childbearing potential are defined as any female who has experienced menarche and who is NOT permanently sterile or postmenopausal. Postmenopausal is defined as 12 consecutive months with no menses without an alternative medical cause. Exclusion Criteria: * A potential subject who meets any of the following criteria will be excluded from participation in the study: * Major systemic diseases - e.g. uncontrolled Diabetes mellitus, systemic lupus erythematosus * Ongoing pregnancy * Photosensitivity, medications affecting sensitivity to light * Tattoos or other highly-pigmented regions in the treated area * Corticosteroids or injections of the treated area within the last 3 months, long-term corticosteroids use * Anticoagulant therapy, bleeding disorders * Hemorrhage in the treated area * Application within 4 to 6 months after radiotherapy * Known or suspected malignancy, history of cancer or any type of malignancy * Febrile conditions, serious illness, chronic infection * Epilepsy * Sensory loss in the treatment area * Deep vein thrombosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Back pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aria Integrative Health
Denver, Colorado, 80211, United States
-
River Oaks Hospital & Clinics
Houston, Texas, 77027, United States
-
Royal Spine Surgery, Scottsdale, AZ, USA
Scottsdale, Arizona, 85260, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can yoga ease back pain when recovery looks unlikely?
- Can a 13-Minute eye exercise routine ease screen strain?
- Can a Longer-Lasting nerve block cut opioid use after spine surgery?
- A phone call could ease chronic pain and depression in older veterans
- Can a gentle electric pulse ease chronic nerve pain?
- Sound waves aimed at the brain could quiet chronic pain